Does GOLIMUMAB Cause Therapy non-responder? 1,256 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 1,256 reports of Therapy non-responder have been filed in association with GOLIMUMAB (SIMPONI ARIA). This represents 1.8% of all adverse event reports for GOLIMUMAB.
1,256
Reports of Therapy non-responder with GOLIMUMAB
1.8%
of all GOLIMUMAB reports
424
Deaths
876
Hospitalizations
How Dangerous Is Therapy non-responder From GOLIMUMAB?
Of the 1,256 reports, 424 (33.8%) resulted in death, 876 (69.7%) required hospitalization, and 600 (47.8%) were considered life-threatening.
Is Therapy non-responder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GOLIMUMAB. However, 1,256 reports have been filed with the FAERS database.
What Other Side Effects Does GOLIMUMAB Cause?
Drug ineffective (17,959)
Rheumatoid arthritis (12,272)
Pain (11,443)
Fatigue (9,626)
Off label use (8,764)
Alopecia (8,394)
Rash (8,331)
Joint swelling (8,264)
Arthralgia (7,968)
Abdominal discomfort (7,902)
What Other Drugs Cause Therapy non-responder?
ETANERCEPT (3,472)
APREMILAST (3,360)
METHOTREXATE (2,965)
RITUXIMAB (2,731)
ADALIMUMAB (2,595)
PREDNISONE (2,563)
TREPROSTINIL (2,289)
INFLIXIMAB (2,122)
TOCILIZUMAB (1,775)
HYDROXYCHLOROQUINE (1,699)
Which GOLIMUMAB Alternatives Have Lower Therapy non-responder Risk?
GOLIMUMAB vs GOLODIRSEN
GOLIMUMAB vs GONADORELIN
GOLIMUMAB vs GONADOTROPHIN, CHORIONIC
GOLIMUMAB vs GOSERELIN
GOLIMUMAB vs GRAMICIDIN